Patient Perceptions and Best Practices in Clinical Trial Supply Management to be Presented by Catalent Executives at Upcoming Asian ISPE Conferences

Share Article

Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics, consumer health products and global clinical supply services, today announced that Mr. Paul Cao, General Manager, Clinical Trial Supply, China, and Ms. Esther Sadler-Williams, Global Director, Strategic Development and Innovation, have been invited to speak at upcoming ISPE events in China and Japan.

Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics, consumer health products and global clinical supply services, today announced that Mr. Yufeng (Paul) Cao, General Manager, Clinical Trial Supply, China, and Ms. Esther Sadler-Williams, Global Director, Strategic Development and Innovation, have been invited to speak at upcoming ISPE events in China and Japan.

Mr. Cao’s presentation, at the ISPE China Annual Spring Conference, on Monday April 11th at 1.30 p.m., is entitled “Best Practice and Considerations for Running Successful Clinical Trials in and from Asia,” and will discuss current trends and challenges facing companies running clinical trials in this market, and strategies to overcome these. A case study demonstrating successful planning through combining clinical supply management and a patient- and site-centric supply network will be presented, while Mr. Cao will also discuss approaches for Asian innovators looking to manage clinical trials in the US and Europe.

AT the ISPE Japan Affiliate General Assembly, on Friday, April 15th at 11.00 a.m., Ms. Sadler-Williams will present “Patient Perceptions of Investigational Medicinal Products”. She will speak as a representative of the Investigational Products Community of Practice Steering Committee, and discuss the findings from the cross-industry group’s patient survey, undertaken with a range of subjects associated with Investigational Medicinal Product (IMP) trials. The presentation will outline key findings including overall patient experience, patient perceptions around labelling and kit design, transport and storage of medicines, as well as behavior associated with returning unused medicines.

Prior to joining Catalent, Mr. Cao was most recently the General Manager for Fisher Clinical Service (Beijing, China). An industry veteran, who is experienced with GMP and FDA certification in China, he has an extensive background in secondary packaging and cold chain distribution. Prior to Fisher he worked for Zuellig Pharma and has extensive experience in drug distribution. Mr. Cao has a Bachelor of Science Degree in Industrial Electrical Automation from Beijing University of Science and Technology and also holds an MBA from Vlerick Leuven Ghent Management School, K. U. Leuven, Belgium. Additionally, he has a Bachelor’s degree in Computer Science & Artificial Intelligence from K. U. Leuven, Belgium.

Ms. Sadler-Williams M.Sc., MRPharmS, is the past EU chair of the ISPE Investigational Products Community of Practice committee. As a pharmacist, she has had nearly 30 years’ experience in various pharmaceutical fields, latterly in clinical supply environments, but she also worked for five years with Sanofi Winthrop, where she was Head of Research Services, managing groups of clinical research associates, medical writers and information/adverse event surveillance specialists. Her previous roles include Principal Pharmacist with the Regional Drug Information Service at St Mary’s Hospital in Manchester, UK, and Pharmacy Manager with Boots the Chemist.

The ISPE China Annual Spring Conference takes place on April 10th – 11th 2016, at the Crowne Plaza Shanghai Noah Square Hotel. For more information on the event visit: http://annualconference.ispe-event.org.cn/EN/

The 2016 ISPE Japan Affiliate General Assembly takes place on April 14th – 15th 2016, at the Tower Hall Funabori, Tokyo. For more information on the event visit: http://www.ispe.gr.jp/ISPE/pdf/2016_nenji.pdf

To arrange a meeting with Catalent executives at these events, contact Richard Kerns at NEPR- richard@nepr.eu.

About Catalent

Catalent is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics, consumer health and global clinical supply services. With over 80 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. Catalent employs approximately 8,700 people, including over 1,000 scientists, at 31 facilities across 5 continents, and in fiscal 2015 generated more than $1.8 billion in annual revenue. Catalent is headquartered in Somerset, N.J. For more information, visit http://www.catalent.com

More products. Better treatments. Reliably supplied.™

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Chris Halling

Richard Kerns
Northern Exposure PR
+44 7974 579202
Email >
Visit website